Mainstay Capital Management’s Alimera Sciences ALIM Stock Holding History

Mainstay Capital Management’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,033	Closed	-$9K	–	114
2019 Q3	$9K	Hold	1,033	–	–	0.01%	100
2019 Q2	$14K	Hold	1,033	–	–	0.01%	105
2019 Q1	$16K	Hold	1,033	–	–	0.01%	86
2018 Q4	$11K	Hold	1,033	–	–	0.01%	88
2018 Q3	$15K	Hold	1,033	–	–	0.01%	313
2018 Q2	$15K	Hold	1,033	–	–	0.01%	296
2018 Q1	$15K	Hold	1,033	–	–	0.01%	225
2017 Q4	$21K	Buy	+1,033	New	+$20.2K	0.02%	217

Other funds holding ALIM

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Mainstay Capital Management's ALIM Position: Q4 2019 in Review

Mainstay Capital Management sold out of Alimera Sciences (ALIM) in Q4 2019, closing a stake of 1,033 shares — an estimated $9K sold.

Mainstay Capital Management first reported a position in ALIM in Q4 2017 and held it in 8 quarters. The position peaked at $21K in Q4 2017. 22 funds tracked by Wall St. Rank hold ALIM as of Q4 2019.

Mainstay Capital Management reported no remaining Alimera Sciences position as of Q4 2019 after selling out during the quarter.
Mainstay Capital Management sold 1,033 Alimera Sciences shares in Q4 2019, an estimated $9K.
Mainstay Capital Management first reported a position in Alimera Sciences in Q4 2017 and held it in 8 quarters.
Mainstay Capital Management's Alimera Sciences position peaked at $21K in Q4 2017.
22 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2019.

Based on Mainstay Capital Management's 13F filing for Q4 2019, filed 21 Jan 2020.